Ondansetron

Ondansetron Injection (2mg/ml) is an intravenous/intramuscular selective 5-HT3 receptor antagonist on the WHO Model List of Essential Medicines. It blocks serotonin 5-HT3 receptors located centrally in the area postrema / chemoreceptor trigger zone (CTZ) and peripherally on vagal nerve terminals in the gastrointestinal tract, halting the emetic reflex cascade. Indicated for prevention and treatment of chemotherapy-induced nausea and vomiting (CINV), radiation-induced emesis, and postoperative nausea and vomiting (PONV).

Ondansetron Tablets (4mg) is an oral selective 5-HT3 receptor antagonist on the WHO Model List of Essential Medicines. It blocks serotonin signaling at 5-HT3 receptors in both the peripheral gastrointestinal vagal afferents and central area postrema. Indicated for prevention and management of nausea and vomiting caused by cytotoxic chemotherapy, radiation therapy, and acute gastroenteritis.

Ondansetron Orally Disintegrating Formulations (4mg/8mg ODT, Oral Disintegrating Strips, and 2mg/5ml Solution) is a fast-acting 5-HT3 receptor antagonist designed for immediate buccal absorption without requiring water. It blocks peripheral vagal serotonin receptors in the gut and central CTZ receptors. Indicated for prevention of nausea and vomiting associated with cancer chemotherapy, radiotherapy, gastroenteritis-associated emesis in pediatric patients, and postoperative recovery.

Ondansetron Orally Disintegrating Formulations (4mg/8mg ODT, Oral Disintegrating Strips, and 2mg/5ml Solution) is a fast-acting 5-HT3 receptor antagonist designed for immediate buccal absorption without requiring water. It blocks peripheral vagal serotonin receptors in the gut and central CTZ receptors. Indicated for prevention of nausea and vomiting associated with cancer chemotherapy, radiotherapy, gastroenteritis-associated emesis in pediatric patients, and postoperative recovery.

Ondansetron Orally Disintegrating Formulations (4mg/8mg ODT, Oral Disintegrating Strips, and 2mg/5ml Solution) is a fast-acting 5-HT3 receptor antagonist designed for immediate buccal absorption without requiring water. It blocks peripheral vagal serotonin receptors in the gut and central CTZ receptors. Indicated for prevention of nausea and vomiting associated with cancer chemotherapy, radiotherapy, gastroenteritis-associated emesis in pediatric patients, and postoperative recovery.

Ondansetron Orally Disintegrating Formulations (4mg/8mg ODT, Oral Disintegrating Strips, and 2mg/5ml Solution) is a fast-acting 5-HT3 receptor antagonist designed for immediate buccal absorption without requiring water. It blocks peripheral vagal serotonin receptors in the gut and central CTZ receptors. Indicated for prevention of nausea and vomiting associated with cancer chemotherapy, radiotherapy, gastroenteritis-associated emesis in pediatric patients, and postoperative recovery.